ArTS Archivio della ricerca di Trieste

MUSTACCHI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.966
NA - Nord America 5.756
AS - Asia 2.468
Continente sconosciuto - Info sul continente non disponibili 316
SA - Sud America 256
AF - Africa 125
OC - Oceania 8
Totale 31.895
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 20.226
US - Stati Uniti d'America 5.691
SG - Singapore 982
CN - Cina 510
FR - Francia 466
UA - Ucraina 396
SE - Svezia 326
GB - Regno Unito 244
VN - Vietnam 235
HK - Hong Kong 234
DE - Germania 223
NL - Olanda 211
BR - Brasile 191
KR - Corea 162
CH - Svizzera 155
FI - Finlandia 139
PL - Polonia 125
RU - Federazione Russa 102
TR - Turchia 77
MA - Marocco 70
IE - Irlanda 66
IN - India 65
BG - Bulgaria 63
BD - Bangladesh 44
RO - Romania 41
CA - Canada 36
ES - Italia 35
AL - Albania 29
AR - Argentina 24
BE - Belgio 24
JP - Giappone 21
EU - Europa 20
IQ - Iraq 19
CI - Costa d'Avorio 17
IR - Iran 16
GR - Grecia 14
PT - Portogallo 14
MX - Messico 13
MY - Malesia 13
DK - Danimarca 12
JO - Giordania 12
AT - Austria 11
PK - Pakistan 11
SA - Arabia Saudita 10
ZA - Sudafrica 10
CL - Cile 9
CZ - Repubblica Ceca 9
IL - Israele 9
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
KE - Kenya 7
AE - Emirati Arabi Uniti 6
SI - Slovenia 6
SM - San Marino 6
TH - Thailandia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
HR - Croazia 5
PY - Paraguay 5
TN - Tunisia 5
JM - Giamaica 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PH - Filippine 4
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
OM - Oman 3
AO - Angola 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
MT - Malta 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CF - Repubblica Centrafricana 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GA - Gabon 1
LB - Libano 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 31.593
Salva come PNG Salva come JPEG
Città #
Rome 1.160
Milan 1.113
Singapore 595
Woodbridge 538
Ashburn 442
Ann Arbor 424
Fairfield 379
Jacksonville 341
Houston 336
Naples 324
Chandler 320
San Jose 320
Hong Kong 230
Florence 227
Wilmington 218
Turin 204
Bologna 201
Seattle 185
Hefei 176
Seoul 161
Trieste 160
Padova 158
Palermo 157
Napoli 138
Cambridge 132
Princeton 120
Bari 114
Council Bluffs 114
Boardman 113
Torino 109
Dallas 101
Columbus 100
Genoa 100
Catania 96
Santa Clara 95
Brescia 91
Ho Chi Minh City 83
Beijing 82
Chicago 78
Cagliari 76
Verona 72
Perugia 63
Casablanca 62
Dublin 61
Bergamo 60
Sofia 59
Zgierz 59
Izmir 57
Lauterbourg 54
Buffalo 46
Hanoi 46
Pescara 45
Monza 44
Moscow 44
Caserta 43
Messina 42
Genova 41
Mountain View 41
Udine 41
Amsterdam 40
Como 40
Los Angeles 38
Dearborn 37
Treviso 37
Venezia 37
Reggio Calabria 36
Vicenza 34
New York 33
Pisa 33
Modena 32
Sassari 32
Lucca 31
London 30
San Diego 30
The Dalles 30
Venice 30
Ancona 29
Taranto 29
Latina 28
Catanzaro 27
Frankfurt am Main 27
Prato 27
Reggio Nell'emilia 26
Parma 25
Livorno 24
Helsinki 23
Pavia 23
Salerno 23
Bremen 22
Foggia 22
Redwood City 22
Siena 22
Novara 21
São Paulo 21
Trento 21
Mumbai 20
Düsseldorf 19
Ferrara 19
Redmond 19
Abbiategrasso 18
Totale 12.228
Salva come PNG Salva come JPEG
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.875
Advances in systemic therapy for metastatic breast cancer: future perspectives 430
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. 295
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 269
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 250
Breast cancer in elderly women: a different reality? Results from the NORA Study 231
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 223
Adjuvant systemic treatment of early breast cancer: The NORA study. 222
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial 222
Role of lifestyles in breast cancer risk: a retrospective analysis of Trieste's female population 217
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. 210
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. 205
Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials 197
Early detection of breast cancer recurrences through periodic follow up - Is it useless? 196
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 196
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study. 194
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study 189
Psychological Response to Cancer: Role of 5-HTTLPR Genetic Polymorphism of Serotonin Transporter 184
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study 177
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study 177
Gene expression profiling in breast cancer: A clinical perspective 176
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 7 years of the 1st GROCTA Trial. 175
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database 175
Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer 174
Cancro del fegato: possibilità di diagnosi precoce 169
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancerdeath: meta-analysis of individual patient data for 10,801 women in 17 randomised trials 169
A multicentre, double blind, randomised trial comparing ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 168
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy. 167
Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast cancer Patients: Results of an Italian Cooperative Study 163
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs 163
Changes in adjuvant treatment of early breast cancer in Italy between 2000 and 2008. The NEMESI study versus the NORA study. 161
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study. 157
Carcinoma dell’ovaio 156
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study. 154
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 152
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 151
Effectiveness of magnetotheraphy in resolution of some early complications of the mastectomy operation. 150
ITALIAN BREAST CANCER ADJUVANT CHEMO-HORMONE THERAPY COOPERATIVE GROUP TRIALS 149
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 8 years of the first GROCTA (Italian Cooperative Group for Adjuvant Chemo-Hormonal Therapy of Breast cancer)Trial. 147
Gli antidoti in Oncologia medica: efficacia, costo e beneficio 145
Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting. J Clin Oncol 30, 2012 (suppl; abstr 586) 142
La metanalisi di Oxford del 2000: riflessioni e commenti 137
The combination of Metoclopramide, Methylprednisolone and Ondansetron against antiblastic - delayed emesis: a randomised Phase II study. 136
Un programme de réhabilitation chez la femme mastectomisée 135
Modulating effect of Lonidamine on Response to Doxorubicin in Metastatic Breast cancer patients: Results from a Multicenter Prospective Randomized Trial. 135
Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17-beta-estradiol and progesterone throughout one entire menstrual cycle 133
Molecular targets of cancer chemotherapy 133
Prevention of chemotherapy-induced early menopause in early breast cancer patients. A phase III multicenter study of GIM Group 132
Extragonadal Germ Cell Tumor: a Clinical Stdy. 127
Il Carcinoma del Fegato: Realtà e Prospettive Epidemiologia 122
Observer variations in mammary thermography: results of a teaching file test carried out in four different centers 119
La communication du diagnostic de cancer 117
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 116
Tamoxifen or Surgery plus Tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial 116
Prolonged Tamoxifen Treatment of Early Breast Cancer: The experience of the Italian Cooperative Group for Chemo-Hormonal Therapy of Early Breast Cancer. 112
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study 104
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. 104
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter “GRETA” trial. 103
Effect of menstrual status on response to adjuvant chemotherapy and /or endocrine therapy. 103
Role of erythropoietin in the oncology patient: critical review of the literature 99
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 90
Totale 31.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.641 0 0 124 154 121 95 101 110 211 171 169 385
2022/20234.469 323 320 351 347 367 472 293 369 427 284 451 465
2023/20243.525 447 401 315 332 273 185 351 326 76 289 283 247
2024/20252.813 274 286 485 246 235 208 167 153 304 171 156 128
2025/20263.209 255 248 242 315 239 313 367 140 385 488 121 96
2026/2027395 99 157 139 0 0 0 0 0 0 0 0 0
Totale 31.895